Hyman SE. Perspective: Revealing molecular secrets. Nature. 2014;508(7494):S20. doi:10.1038/508S20a
Rees E, Kirov G, Walters JT, et al. Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia. Transl Psychiatry. 2015;5:e607. doi:10.1038/tp.2015.99
Singh T, Kurki MI, Curtis D, et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci. 2016;19(4):571-7. doi:10.1038/nn.4267
Bergen SE, O’Dushlaine CT, Ripke S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17(9):880-6. doi:10.1038/mp.2012.73
Szatkiewicz JP, O’Dushlaine C, Chen G, et al. Copy number variation in schizophrenia in Sweden. Mol Psychiatry. 2014;19(7):762-73. doi:10.1038/mp.2014.40
Xu Q, Wu X, Li M, et al. Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. Pharmacogenomics J. 2016;16(4):357-65. doi:10.1038/tpj.2015.61
Padmanabhan JL, Nanda P, Tandon N, et al. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. J Psychiatr Res. 2016;77:52-8. doi:10.1016/j.jpsychires.2016.02.015
Hyman SE. Revolution stalled. Sci Transl Med. 2012;4(155):155cm11. doi:10.1126/scitranslmed.3003142
Juraeva D, Haenisch B, Zapatka M, et al. Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia. PLoS Genet. 2014;10(6):e1004345. doi:10.1371/journal.pgen.1004345
Lee H, Byrne EM, Hultman CM, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol. 2015;44(5):1706-21. doi:10.1093/ije/dyv136